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I read with great interest the paper by Allen et al. on the contribution of electrodiagnostic 
errors to the misdiagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) 
(1).  
The authors retrospectively reviewed data from 86 patients who had received the diagnosis 
and concluded that 39 (45%) did not have CIDP. Amongst those, data were analyzed from 
29.   
Thirteen (45%) were found to have initially correctly-interpreted electrophysiological data, 
but only one, with CMT4C, demonstrated demyelinating electrophysiology. The authors do 
not detail whether this patient had, albeit asymmetrical, proximal weakness which may 
explain a misdiagnosis or concurrent diagnosis of CIDP (2). The other patients surprisingly 
had normal results, axonopathy or motor neuron disease.  
Misinterpreted initial studies with reported “demyelinating” or “mixed axonal and 
demyelinating” findings were observed in 16 subjects. Although similarly due to various 
reasons and different final diagnoses (axonal neuropathy, compressive neuropathy, motor 
neuron disease or even normal), none, in short, met minimal EFNS/PNS electrodiagnostic 
requirements for demyelination (3).  
Electrodiagnostic misinterpretation is an important issue to consider in CIDP misdiagnosis 
but as illustrated in this study, may occur when subjective interpretations are made without 
regard for existing highly sensitive and specific criteria that are clearly described and easy to 
apply (4). This would therefore appear readily remediable if guidelines were simply used.  
The authors’ recommendation regarding neurophysiology training programmes is appropriate 
but the fact they found that nearly half of misdiagnosed cases actually had a correctly-
interpreted study, raises the issue of clinical diagnosis as a fundamental problem. With regard 
to the incorrectly-interpreted electrodiagnostic studies, the presence of motor neuron disease, 
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and even more so, of small fibre neuropathy or no neuropathy, equally enhances this concern 
regarding the clinical diagnosis/suspicion, which is hard to reconcile with CIDP. In these 
patients, the question is how any electrophysiological interpretation could possibly have 
suggested CIDP?  
Of note, a minority (30.5%) of misdiagnosed cases met clinical EFNS/PNS criteria for 
“atypical CIDP”, and none for “typical CIDP”. “Atypical CIDP” represents a very diverse 
group (3), which may occasionally lead to erroneous diagnostic considerations. However, 
although the temptation to attempt treatment in selected cases may be at times 
understandable, clinical judgement is essential to differentiate for example, motor neuron 
disease from possible Lewis-Sumner syndrome, or length-dependent axonal neuropathy from 
possible sensory ataxic CIDP. That 69.5% of misdiagnosed cases did not meet any clinical 
criteria for CIDP is perplexing and highly concerning. 
The authors rightly make several important suggestions to eradicate electrophysiological 
misdiagnosis but, for a start, clinical findings need to take priority over any test results, 
including electrophysiology or mildly abnormal cerebrospinal fluid protein levels. Reliance 
on subjective amelioration post-treatment, as demonstrated in the authors’ previous work (5), 
also represents a serious clinical failure, likely as, if not more, problematic than 
electrophysiology, because it may result in unnecessarily prolonged treatment. 
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